Futuristic Exploration of Addiction Neuroscience in the Genomic Era

References

• Volkow ND, Boyle M. Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry. 2018;175(8):729–740. PMID: 29690790. doi:10.1176/appi.ajp.2018.17101174
   PubMed Web of Science ®Google Scholar
• McLellan AT, Koob GF, Volkow ND. Preaddiction-A missing concept for treating substance use disorders. JAMA Psychiatry. 2022;79(8):749–751. PMID: 35793096. doi:10.1001/jamapsychiatry.2022.1652
   PubMed Web of Science ®Google Scholar
• Ahmed R, Blum K, Thanos P. Epigenetic Effects of psychoactive drugs. Curr Pharm Des. 2023;29(27):2124–2139. PMID: 37415372. doi:10.2174/1381612829666230706143026
   PubMed Web of Science ®Google Scholar
• Gold MS, Baron D, Bowirrat A, Blum K. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): do homo sapiens acquire or have a reward deficiency syndrome? J Neurol Sci. 2020;418:117137. PMID: 32957037; PMCID: PMC7490287. doi:10.1016/j.jns.2020.117137
   PubMed Web of Science ®Google Scholar
• García-Rivera BR, García-Alcaraz JL, Mendoza-Martínez IA, et al. Influence of COVID-19 pandemic uncertainty in negative emotional states and resilience as mediators against suicide ideation, drug addiction and alcoholism. Int J Environ Res Public Health. 2021;18(24):12891. PMID: 34948502; PMCID: PMC8701151. doi:10.3390/ijerph182412891
   PubMed Web of Science ®Google Scholar
• Maldonado R, Calvé P, García-Blanco A, Domingo-Rodriguez L, Senabre E, Martín-García E. Vulnerability to addiction. Neuropharmacology. 2021;186:108466. PMID: 33482225. doi:10.1016/j.neuropharm.2021.108466
   PubMed Web of Science ®Google Scholar
• Volkow ND, Baler RD. NOW vs LATER brain circuits: implications for obesity and addiction. Trends Neurosci. 2015;38(6):345–352. PMID: 25959611. doi:10.1016/j.tins.2015.04.002
   PubMed Web of Science ®Google Scholar
• Blum K, Noble EP, Sheridan PJ, et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA. 1990;263(15):2055–2060. PMID: 1969501. doi:10.1001/jama.1990.03440150063027
   PubMed Web of Science ®Google Scholar
• Cadet JL, Jayanthi S. Epigenetics of addiction. Neurochem Int. 2021;147:105069. PMID: 33992741; PMCID: PMC8260024. doi:10.1016/j.neuint.2021.105069
   PubMed Web of Science ®Google Scholar
• Russell VA. Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder--The spontaneously hypertensive rat. Neurosci Biobehav Rev. 2003;27(7):671–682. PMID: 14624811. doi:10.1016/j.neubiorev.2003.08.010
   PubMed Web of Science ®Google Scholar
• Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics. 1995;5(3):121–141. PMID: 7550364. doi:10.1097/00008571-199506000-00001
   PubMedGoogle Scholar
• Blum K, Sheridan PJ, Wood RC, et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med. 1996;89(7):396–400. PMID: 8774539; PMCID: PMC1295855. doi:10.1177/014107689608900711
   PubMed Web of Science ®Google Scholar
• Blum K, Bowirrat A, Elman I, et al. Evidence for the DRD2 gene as a determinant of Reward Deficiency Syndrome (RDS). Clin Exp Psychol. 2023;9(4):8–11. PMID: 37560184; PMCID: PMC10411139.
   PubMedGoogle Scholar
• Borsook D, Linnman C, Faria V, Strassman AM, Becerra L, Elman I. Reward deficiency and anti-reward in pain chronification. Neurosci Biobehav Rev. 2016;68:282–297. PMID: 27246519. doi:10.1016/j.neubiorev.2016.05.033
   PubMed Web of Science ®Google Scholar
• Fried L, Modestino EJ, Siwicki D, et al. Hypodopaminergia and “Precision Behavioral Management” (PBM): it is a generational family affair. Curr Pharm Biotechnol. 2020;21(6):528–541. PMID: 31820688. doi:10.2174/1389201021666191210112108
   PubMed Web of Science ®Google Scholar
• Baik JH. Stress and the dopaminergic reward system. Exp Mol Med. 2020;52(12):1879–1890. PMID: 33257725; PMCID: PMC8080624. doi:10.1038/s12276-020-00532-4
   PubMed Web of Science ®Google Scholar
• Hagerty SL, York Williams SL, Bidwell LC, et al. DRD2 methylation is associated with executive control network connectivity and severity of alcohol problems among a sample of polysubstance users. Addict Biol. 2020;25(1):e12684. PMID: 30370960; PMCID: PMC7326368. doi:10.1111/adb.12684
   PubMed Web of Science ®Google Scholar
• Green CL, Nahhas RW, Scoglio AA, Elman I. Post-traumatic stress symptoms in pathological gambling: potential evidence of anti-reward processes. J Behav Addict. 2017;6(1):98–101. PMID: 28274137; PMCID: PMC5572998. doi:10.1556/2006.6.2017.006
   PubMed Web of Science ®Google Scholar
• Blum K, Green R, Smith J, Llanos-Gomez L, Baron D, Badgaiyan RD. Hypothesizing high negative emotionality as a function of Genetic Addiction Risk Severity (GARS) Testing in Alcohol Use Disorder (AUD). J Syst Integr Neurosci. 2020;7(2). PMID: 35096419; PMCID: PMC8793765. doi:10.15761/jsin.1000245
   Google Scholar
• Traynor JR, Moron JA. Opioid research in the time of the opioid crisis. Br J Pharmacol. 2023;180(7):793–796. PMID: 36813266. doi:10.1111/bph.16043
   PubMed Web of Science ®Google Scholar
• Dennen AC, Blum K, Braverman RE, et al. How to combat the global opioid crisis. CPQ Neurol Psychol. 2023;5(4):93. PMID: 36812107; PMCID: PMC9937628.
   PubMedGoogle Scholar
• Downs BW, Blum K, Baron D, et al. Death by opioids: are there non-addictive scientific solutions? J Syst Integr Neurosci. 2019;5(2). PMID: 31824737; PMCID: PMC6904107. doi:10.15761/JSIN.1000211
   Google Scholar